Search Results
Search for other papers by Maria Wielsøe in
Google Scholar
PubMed
Search for other papers by Christian Bjerregaard-Olesen in
Google Scholar
PubMed
Search for other papers by Peder Kern in
Google Scholar
PubMed
Institute for Nursing and Health Science, University of Greenland, Nuuk, Greenland
Search for other papers by Eva Cecilie Bonefeld-Jørgensen in
Google Scholar
PubMed
Introduction Breast cancer is the most common cancer among women, and tumor growth is often hormone dependent ( Ferlay et al . 2015 ). Estrogen receptors (ER) and progesterone receptor are expressed in up to 75% of all breast cancer tumors
Molecular and Cellular Gynecological Endocrinology Laboratory (MCGEL), Department of Physiology, Department of Reproductive Medicine and Child Development, University of Pisa, Pisa 56100, Italy
Search for other papers by Xiao-Dong Fu in
Google Scholar
PubMed
Search for other papers by Lorenzo Goglia in
Google Scholar
PubMed
Search for other papers by Angel Matias Sanchez in
Google Scholar
PubMed
Search for other papers by Marina Flamini in
Google Scholar
PubMed
Search for other papers by Maria S Giretti in
Google Scholar
PubMed
Search for other papers by Veronica Tosi in
Google Scholar
PubMed
Search for other papers by Andrea R Genazzani in
Google Scholar
PubMed
Search for other papers by Tommaso Simoncini in
Google Scholar
PubMed
Introduction Progesterone is a major regulator of breast epithelial cell proliferation and differentiation; however, the connection between this hormone and breast cancer is still a matter of debate ( Yager & Davidson 2006 , Hankinson & Eliassen
Search for other papers by Vasily N Aushev in
Google Scholar
PubMed
Search for other papers by Kalpana Gopalakrishnan in
Google Scholar
PubMed
Search for other papers by Susan L Teitelbaum in
Google Scholar
PubMed
Search for other papers by Humberto Parada Jr in
Google Scholar
PubMed
Search for other papers by Regina M Santella in
Google Scholar
PubMed
Search for other papers by Marilie D Gammon in
Google Scholar
PubMed
Department of Pediatrics, Icahn School of Medicine at Mount Sinai, New York, New York, USA
Department of Medicine, Hematology and Medical Oncology, Icahn School of Medicine at Mount Sinai, New York, New York, USA
Department of Oncological Sciences, Icahn School of Medicine at Mount Sinai, New York, New York, USA
Search for other papers by Jia Chen in
Google Scholar
PubMed
progression of breast cancer ( Darbre & Harvey 2014 , Giulivo et al. 2016 , Benjamin et al. 2017 ), but existing data on this subject are scarce, especially for humans. Our study focuses on two specific phthalate and paraben congeners: diethyl
Search for other papers by Tanya K Day in
Google Scholar
PubMed
Dame Roma Mitchell Cancer Research Laboratories, School of Paediatrics and Reproductive Health, School of Agriculture, Discipline of Medicine, Hanson Institute, Adelaide Prostate Cancer Research Centre, The University of Adelaide, Adelaide, South Australia, Australia
Search for other papers by Tina Bianco-Miotto in
Google Scholar
PubMed
Introduction Numerous diseases are associated with abnormal hormonal regulation including breast and prostate cancers. Breast cancer is a heterogeneous disease that can be classified in many ways. The most primary classification is by hormone
Search for other papers by T Kogai in
Google Scholar
PubMed
Search for other papers by K Taki in
Google Scholar
PubMed
Search for other papers by G A Brent in
Google Scholar
PubMed
concentrate iodide to a similar degree as that seen in the thyroid, producing milk with an iodine concentration of 20–700 μg/l ( Simon et al. 2002 b ). NIS expression has been demonstrated in more than 80% breast cancer tissue, although the fraction of
Search for other papers by Alyson Murray in
Google Scholar
PubMed
Search for other papers by Stephen F Madden in
Google Scholar
PubMed
Search for other papers by Naoise C Synnott in
Google Scholar
PubMed
Search for other papers by Rut Klinger in
Google Scholar
PubMed
Search for other papers by Darran O'Connor in
Google Scholar
PubMed
Search for other papers by Norma O'Donovan in
Google Scholar
PubMed
Search for other papers by William Gallagher in
Google Scholar
PubMed
Search for other papers by John Crown in
Google Scholar
PubMed
UCD Clinical Research Centre, St. Vincent’s University Hospital, Dublin, Ireland
Search for other papers by Michael J Duffy in
Google Scholar
PubMed
have been widely exploited as therapeutic targets in cancer (i.e., ER in breast cancer ( EBCTCG et al. 2011 ) and AR in prostate cancer ( Valenca et al. 2015 )), less work has been carried out on targeting VDR. There are, however, several
Search for other papers by Adena E Rosenblatt in
Google Scholar
PubMed
Search for other papers by Maria Ines Garcia in
Google Scholar
PubMed
Search for other papers by Leah Lyons in
Google Scholar
PubMed
Search for other papers by Yingqiu Xie in
Google Scholar
PubMed
Search for other papers by Carol Maiorino in
Google Scholar
PubMed
Search for other papers by Laurent Désiré in
Google Scholar
PubMed
Search for other papers by Joyce Slingerland in
Google Scholar
PubMed
Search for other papers by Kerry L Burnstein in
Google Scholar
PubMed
implicated in breast cancer cell invasion and metastasis ( Fritz et al . 2002 , Burbelo et al . 2004 , Baugher et al . 2005 , Chan et al . 2005 , Xie & Haslam 2008 ). Furthermore, Rho GTPases may also function as mediators of epidermal growth factor
Search for other papers by Aleksandra M Ochnik in
Google Scholar
PubMed
Search for other papers by Robert C Baxter in
Google Scholar
PubMed
, in the inhibition of the human epidermal growth factor (EGF) receptor-2 (HER2) in women with HER2-positive breast cancer and the blockade of EGF receptor kinase activity in non-small-cell lung cancer. In contrast, the insulin-like growth factor (IGF
Search for other papers by L Zeng in
Google Scholar
PubMed
Search for other papers by H A Zielinska in
Google Scholar
PubMed
Search for other papers by A Arshad in
Google Scholar
PubMed
Search for other papers by J P Shield in
Google Scholar
PubMed
Search for other papers by A Bahl in
Google Scholar
PubMed
Search for other papers by J M P Holly in
Google Scholar
PubMed
Search for other papers by C M Perks in
Google Scholar
PubMed
Introduction Breast cancer is the most common malignancy in women with a lifetime risk of one in eight. In all Western societies women present with breast cancer are increasingly likely to also suffer from co-morbid conditions such as diabetes and
Search for other papers by Etienne Leygue in
Google Scholar
PubMed
Search for other papers by Leigh C Murphy in
Google Scholar
PubMed
Introduction The critical role of estrogen in human breast cancer is undisputed. The practical consequences of the concept of inhibiting the mitogenic action of estrogen on breast cancer cells have been the successful establishment of the endocrine